Linked Life Data

17689382

Source:http://linkedlifedata.com/resource/pubmed/id/17689382

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17689382rdf:typepubmed:Citationlld:pubmed
pubmed-article:17689382lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0242456lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0006405lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0020811lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0376196lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0678257lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C0444454lld:lifeskim
pubmed-article:17689382lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:17689382pubmed:issue4lld:pubmed
pubmed-article:17689382pubmed:dateCreated2007-8-10lld:pubmed
pubmed-article:17689382pubmed:abstractTextInjection drug use (IDU) accounts for 70 percent of HIV cases in Ukraine. Until buprenorphine maintenance therapy (BMT) was introduced, few effective strategies aimed at achieving reduction in illicit drug use were available as a conduit to anti-retroviral therapy (ARV) among IDUs.lld:pubmed
pubmed-article:17689382pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:languageenglld:pubmed
pubmed-article:17689382pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:citationSubsetIMlld:pubmed
pubmed-article:17689382pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17689382pubmed:statusMEDLINElld:pubmed
pubmed-article:17689382pubmed:monthAuglld:pubmed
pubmed-article:17689382pubmed:issn1873-4758lld:pubmed
pubmed-article:17689382pubmed:authorpubmed-author:AlticeFrederi...lld:pubmed
pubmed-article:17689382pubmed:authorpubmed-author:BruceR...lld:pubmed
pubmed-article:17689382pubmed:authorpubmed-author:DvoryakSergey...lld:pubmed
pubmed-article:17689382pubmed:authorpubmed-author:SyllaLaurieLlld:pubmed
pubmed-article:17689382pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17689382pubmed:volume18lld:pubmed
pubmed-article:17689382pubmed:ownerNLMlld:pubmed
pubmed-article:17689382pubmed:authorsCompleteYlld:pubmed
pubmed-article:17689382pubmed:pagination326-8lld:pubmed
pubmed-article:17689382pubmed:dateRevised2011-8-1lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:meshHeadingpubmed-meshheading:17689382...lld:pubmed
pubmed-article:17689382pubmed:year2007lld:pubmed
pubmed-article:17689382pubmed:articleTitleHIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.lld:pubmed
pubmed-article:17689382pubmed:affiliationYale University AIDS Program, New Haven, CT 06510-2283, United States. robert.bruce@yale.edu <robert.bruce@yale.edu>lld:pubmed
pubmed-article:17689382pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17689382pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17689382lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17689382lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17689382lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17689382lld:pubmed